NO20064214L - Oxydecahydronaphthalen-modulatorer for HM74 - Google Patents

Oxydecahydronaphthalen-modulatorer for HM74

Info

Publication number
NO20064214L
NO20064214L NO20064214A NO20064214A NO20064214L NO 20064214 L NO20064214 L NO 20064214L NO 20064214 A NO20064214 A NO 20064214A NO 20064214 A NO20064214 A NO 20064214A NO 20064214 L NO20064214 L NO 20064214L
Authority
NO
Norway
Prior art keywords
oxydecahydronaphthalene
modulators
oxydecalin
molecules
prepare
Prior art date
Application number
NO20064214A
Other languages
English (en)
Norwegian (no)
Inventor
Haifeng Eishingdrelo
Anne Minnich
Theresa Kuntzweiler
Michael Angelastro
Stephan Henke
Original Assignee
Aventis Pharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Inc filed Critical Aventis Pharma Inc
Publication of NO20064214L publication Critical patent/NO20064214L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Steroid Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pyrane Compounds (AREA)
NO20064214A 2004-02-20 2006-09-18 Oxydecahydronaphthalen-modulatorer for HM74 NO20064214L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US54601204P 2004-02-20 2004-02-20
PCT/US2005/004095 WO2005082352A1 (en) 2004-02-20 2005-02-10 Oxydecahydronaphthalene modulators of hm74

Publications (1)

Publication Number Publication Date
NO20064214L true NO20064214L (no) 2006-09-18

Family

ID=34910747

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20064214A NO20064214L (no) 2004-02-20 2006-09-18 Oxydecahydronaphthalen-modulatorer for HM74

Country Status (21)

Country Link
US (2) US7264937B2 (https=)
EP (1) EP1718293A1 (https=)
JP (1) JP2007526917A (https=)
KR (1) KR101145693B1 (https=)
CN (1) CN1929833A (https=)
AR (1) AR047708A1 (https=)
AU (1) AU2005216878B2 (https=)
BR (1) BRPI0507916A (https=)
CA (1) CA2556757C (https=)
CR (1) CR8537A (https=)
EC (1) ECSP066776A (https=)
IL (1) IL177106A (https=)
MA (1) MA28368A1 (https=)
ME (2) MEP17008A (https=)
NO (1) NO20064214L (https=)
RS (1) RS20060472A (https=)
RU (1) RU2006133539A (https=)
TN (1) TNSN06235A1 (https=)
TW (1) TWI354552B (https=)
WO (1) WO2005082352A1 (https=)
ZA (1) ZA200606687B (https=)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004083388A2 (en) * 2003-03-14 2004-09-30 Bristol-Myers Squibb Company Polynucleotide encoding a novel human g-protein coupled receptor variant of hm74, hgprbmy74
CN101115726A (zh) 2004-12-03 2008-01-30 先灵公司 作为cb1拮抗剂的取代哌嗪
AR059021A1 (es) * 2006-01-18 2008-03-05 Schering Corp Moduladores de receptores cannabinoides
US20100197564A1 (en) * 2007-04-19 2010-08-05 Schering Corporation Diaryl morpholines as cb1 modulators
US8623873B2 (en) * 2007-06-28 2014-01-07 Intervet Inc. Substituted piperazines as CB1 antagonists
US20100286160A1 (en) * 2007-06-28 2010-11-11 Intervet Inc. Substituted piperazines as cb1 antagonists

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4522811A (en) 1982-07-08 1985-06-11 Syntex (U.S.A.) Inc. Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides
US5674908A (en) * 1993-12-20 1997-10-07 Life Technologies, Inc. Highly packed polycationic ammonium, sulfonium and phosphonium lipids
DE19624154A1 (de) * 1996-06-18 1998-01-08 Hoechst Ag Ringannelierte Dihydropyrane, Verfahren zur Herstellung sowie deren Verwendung
US6555339B1 (en) 1997-04-14 2003-04-29 Arena Pharmaceuticals, Inc. Non-endogenous, constitutively activated human protein-coupled receptors
EP1007563A4 (en) * 1997-06-12 2003-04-16 Smithkline Beecham Corp HM74A RECEPTOR
GB0021484D0 (en) * 2000-09-01 2000-10-18 Boehringer Ingelheim Pharma Method for identifying substances which positively influence inflammatory conditions of chronic inflammatory airway diseases

Also Published As

Publication number Publication date
RS20060472A (sr) 2008-11-28
MEP17008A (hr) 2010-06-10
IL177106A (en) 2012-03-29
RU2006133539A (ru) 2008-03-27
AR047708A1 (es) 2006-02-08
AU2005216878A1 (en) 2005-09-09
CR8537A (es) 2007-03-05
CN1929833A (zh) 2007-03-14
CA2556757C (en) 2011-05-03
TWI354552B (en) 2011-12-21
ECSP066776A (es) 2006-11-16
US20080045586A1 (en) 2008-02-21
WO2005082352A1 (en) 2005-09-09
US7264937B2 (en) 2007-09-04
CA2556757A1 (en) 2005-09-09
ME00059B (me) 2010-06-10
JP2007526917A (ja) 2007-09-20
EP1718293A1 (en) 2006-11-08
IL177106A0 (en) 2006-12-10
TW200539864A (en) 2005-12-16
ZA200606687B (en) 2008-02-27
US20050187263A1 (en) 2005-08-25
KR20060127982A (ko) 2006-12-13
AU2005216878B2 (en) 2010-06-17
KR101145693B1 (ko) 2012-05-25
BRPI0507916A (pt) 2007-07-10
TNSN06235A1 (en) 2007-12-03
MA28368A1 (fr) 2006-12-01

Similar Documents

Publication Publication Date Title
NO20081034L (no) Pyrimidinforbindelser som serotoninreseptormodulatorer
DK1881967T3 (da) Substituerede benzo (D) isoaxol-3-yl-amin-forbindelser som analgetika
BR112013005116A2 (pt) moduladores e métodos de uso
DK2025670T3 (da) Anvendelse af 3-phenylthio-1H-indol-1-eddikesyre-derivater som modulatorer af CRTh2-receptor aktivitet
PL1636190T3 (pl) Trwały kryształ związku 4-oksochinoliny
AR082381A1 (es) Composicion acuosa que contiene bromhexina
IL182685A0 (en) Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflammatory diseases
CL2007001972A1 (es) Ester isopropilico del acido 4-[6-(6-metanosulfonil-2-metilpiridin-3-ilamino)-5-metilpirimidin-4-iloxi]piperidin-1-carboxilico, moduladores del metabolismo; composicion farmaceutica; y su uso para tratar trastornos metabolicos.
BR112013014119A8 (pt) Novos moduladores e métodos de uso
ATE520769T1 (de) Enzymatische hydrolyse von biomassen mit hohem dm (dry matter)-gehalt
DK1656345T3 (da) Cykliske derivater som modulatorer af chemokinreceptoraktivitet
EA201001332A1 (ru) Соединения и композиции в качестве модуляторов активности gpr119
DK1492789T3 (da) Tropanderivater som CCR5-modulatorer
DE602005003446D1 (de) Blade Computer mit Notstromversorgung mittels Kondensatoren
EP2227222A4 (en) REVIVAL LIQUID
MA28985B1 (fr) Analogues de loxapine et methodes d'utilisation
NO20081618L (no) Anvendelse av proteiner som en antiskumdannende komponent i drivstoff
HUE042138T2 (hu) Készítmények érett dendritikus sejtek elõállítására
ZA200703389B (en) Novel sulphonamide derivatives as glucocorticoid receptor modulators for the treatment of inflammatory diseases
DE602006004463D1 (de) Kristallform von asenapinmaleat
EA200802072A1 (ru) Ликопин для лечения нарушения обмена веществ
DK2049519T3 (da) Cykliske derivater som modulatorer af chemokinreceptoraktivitet
NO20064214L (no) Oxydecahydronaphthalen-modulatorer for HM74
NO20064237L (no) Furosemide modulatorer for HM74
EA201200017A1 (ru) Новая кристаллическая форма пемироласта

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application